首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1621971

止痛藥輸液幫浦市場（按產品、應用和地區劃分）2024 年至 2031 年

Analgesic Infusion Pumps Market By Product (Epidural Pumps, Intrathecal Pumps, Patient-Controlled Analgesia Pump (PCA)), By Application (Hospitals, Home Care, Ambulatory Surgical Centers), And Region for 2024-2031

出版日期: 2024年09月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

止痛藥輸液幫浦市場評估，2024-2031

2023 年止痛藥輸液幫浦市場規模價值 27.5 億美元。輸液幫浦是癌症、糖尿病等慢性疾病患者常用來克服輸送相關問題的醫療設備。

老年人慢性疼痛的增加、手術過程中疼痛管理的需求不斷增加以及全球手術數量的增加，正在推動對止痛藥輸液幫浦的需求激增。因此，預計目前市場從 2024 年到 2031 年的複合年增長率約為 5.3%，到 2031 年市場規模達到 30.5 億美元。

止痛藥輸液幫浦市場定義/概述

止痛藥輸液幫浦是一種用於將止痛藥直接輸送到患者體內的醫療設備。透過提供一致且精確的止痛藥流，這些幫浦可以有效地控制疼痛並改善患者的生活品質。這些解決方案對於產科、末期疾病、術後和創傷患者特別有用。此幫浦可編程為在一段時間內施用特定劑量，確保穩定釋放止痛藥。

慢性疼痛的盛行率在所有年齡層中，尤其是老年族群呈現上升趨勢，包括由慢性下背痛症候群、複雜性局部疼痛症候群（CRPS）、心肌梗塞、脊髓損傷和腦性麻痺引起的疼痛。

推動輸液幫浦採用的因素有哪些？

慢性疼痛，如關節炎、癌症疼痛和神經性疼痛，在全世界肥胖、老年人和其他年齡群體中越來越普遍，對疼痛管理方案的需求也隨之增加。需求也日益增加泵浦。同樣，手術後緩解疼痛的藥物注射器的需求也為止痛藥輸液幫浦市場創造了空間。

此外，透過使用人工智慧和互聯健康平台等智慧功能，精確劑量控制和遠端監控等持續進步都成為可能，促進了便攜式、用戶友好型解決方案的開發。因此，泵浦技術的改進正在提高止痛藥輸液幫浦的功能和使用者體驗。

此外，由於提供治療效益和患者滿意度的措施和教育活動，類似這些幫浦的有效疼痛管理解決方案的採用正在增加。人們越來越意識到在家庭保健和門診手術中心使用止痛藥輸液幫浦可以減少住院時間並使疼痛管理個人化。

此外，新興經濟體的高可支配收入也推動了銷售，因為它改善了獲得醫療服務和先進醫療技術（如止痛藥輸液泵）的機會。

儘管成本高昂且監管障礙重重，但止痛藥輸液幫浦市場預計在未來幾年仍將繼續成長。

高成本會阻礙止痛藥輸液幫浦市場的成長嗎？

開發和維護技術先進的輸液幫浦的成本會影響醫療機構的採用率，特別是在資源貧乏和低收入的機構。這是因為所使用的針頭和注射器進一步增加了整體成本，並可能阻止患者獲得先進的治療選擇。

醫療設備受到嚴格的監管要求，這可能會延長審批時間並增加開發成本，從而減慢上市時間。這筆財務支出很可能落在製造商和醫療保健提供者的身上。

雖然口服藥物、神經阻斷等非侵入性技術以及物理治療等替代性疼痛管理方法已被證明是有效的，但泵在某些情況下可能具有優勢，並且可能引起醫療保健專業人員的擔憂。

也需要進行適當的訓練以避免人為錯誤，因為人為錯誤通常會導致劑量不足或過量。這些風險正在對止痛藥輸液幫浦市場的銷售產生重大影響。

技術限制（例如與現有醫療保健系統和連接設備的整合）使其變得複雜、昂貴且容易受到網路威脅。此類技術錯誤以及相容性問題大大降低了採用率。

Acmens 按類別分類

哪個產品類別佔據止痛藥輸液幫浦市場主導地位？

慢性病在所有年齡層（尤其是老年人）的盛行率不斷上升，這就要求患者需要舒適、可自行治療的治療方案，從而提高患者自控鎮痛泵的使用率。。預計這項需求將有助於擴大全球市場規模。醫療保健專業人員對患者控制鎮痛泵的需求日益增加，以管理患者的術後疼痛、慢性疼痛管理和分娩鎮痛。

家庭醫療保健採用便攜式患者控制止痛幫浦正在推動全球市場趨勢。與其他類型的泵浦相比，這些設備更具成本效益，因此越來越多的患者更喜歡它們，從而推動了市場的發展。透過縮短住院時間，它將能夠降低成本並實現遠端監控。因此，醫療保健製造商正專注於符合監管和行業標準的患者控制止痛幫浦。

此外，隨著人工智慧、MI、物聯網 (IoT) 和其他先進技術的集成，這些藥物傳輸系統將實現現代化，從而提供安全性、效率、遠端監控和準確性。

哪些因素會影響居家照護產業的發展？

根據經過驗證的市場研究，預計家庭護理領域將成為預測期內成長最快的領域。以患者為中心的護理和個人化治療方案的需求日益增長，推動了止痛藥輸液幫浦中遠端監控和遠距醫療功能的整合應用。

此外，老年人和病人越來越喜歡在熟悉舒適的環境中接受治療，這也推動了對家用醫療設備的需求。癌症、神經病變和關節炎等伴有急性疼痛的慢性疾病盛行率很高，這可能會讓錢包吃不消，與長期住院相比，成本效益高的慢性疼痛管理和家庭護理的價值凸顯出來。以病人為基礎的照護。

由於醫院面臨容量課題且患者尋求盡量減少接觸病毒，COVID-19 疫情加速了家庭護理服務的採用。這場疫情凸顯了家庭保健的重要性，包括使用止痛藥輸液幫浦。

Acmens 按國家分類

哪些因素推動北美在止痛藥輸液幫浦市場佔有領先佔有率？

由於久坐的生活方式日益增加、飲食習慣和地理位置的改變，包括關節炎、下背部疼痛和神經性疼痛在內的慢性疼痛正在增加。這促使止痛藥輸液幫浦等疼痛管理解決方案的市場不斷成長。該公司的主要重點是確保止痛藥輸液幫浦在推出市場之前符合嚴格的安全性和有效性標準，從而贏得醫護人員和患者的信任。

此外，北美人口老化，更容易患慢性病，增加了對包括疼痛管理在內的醫療保健服務的需求。因此，該地區對疼痛治療的需求為止痛藥輸液幫浦創造了有利可圖的機會。

該地區擁有完善的醫療器材分銷網絡和高效的供應鏈。這使得止痛藥輸液幫浦在整個醫療保健機構中隨時可用。高水準的醫療保健支出也促進了先進醫療技術的採用，包括止痛藥輸液泵，以改善患者護理和治療效果。由於疼痛管理解決方案的進步，北美在止痛藥輸液幫浦市場保持主導地位。

對先進醫療技術日益增長的需求將如何影響亞太地區止痛藥輸液幫浦市場？

對先進醫療技術的需求通常與醫療專業人員和患者對這些技術的認識和理解的提高相伴而生。因此，醫療專業人員對止痛藥輸注幫浦在有效疼痛管理方面的益處的瞭解增加，可能會促使他們採用它們。鑑於對技術的需求，預計亞太市場在預測期內將顯著增長。

對先進醫療技術日益增長的需求正在鼓勵政府當局支持和投資止痛藥輸液泵領域的研究和開發。因此，該地區可能會開發出更為複雜、更易於使用的設備，具有增強的功能、更高的安全性和更高的藥物傳輸精度。同樣，亞太地區政府和私人醫療保健提供者在醫療保健方面的支出增加也為止痛輸液幫浦市場創造了成長機會。

對止痛藥輸液幫浦的需求不斷增長，吸引了國內外製造商進入亞太市場。競爭日益激烈，推動了新型止痛藥輸液泵的開發，這些輸液泵具有遠端監控、推注給藥、與電子病歷集成等功能，提高了可及性、成本效益和質量，最終可能使醫療保健受益提供者和患者。

競爭格局

受快速的技術創新和對有效疼痛管理解決方案日益增長的需求的推動，止痛藥輸液幫浦市場競爭激烈。市場競爭對手不斷努力提高輸液泵的效率、安全性和整體性能以滿足不斷變化的需求，從而形成了該領域的動態競爭環境。

The increasing prevalence of chronic pain among the elderly, a growing demand for pain management during surgical procedures, and a rising number of surgeries performed worldwide is thereby surging demand for analgesic infusion pumps. Thus, the current market will grow at a (CAGR) of around 5.3% from 2024 to 2031, reaching a market size of worthUSD 3.05 Billion by 2031.

Analgesic Infusion Pumps Market: Definition/Overview

Analgesic infusion pumps are medical devices designed to deliver pain-relieving medications directly into a patient's body. By providing a constant and precise flow of analgesics, these pumps can effectively manage pain and improve the quality of life for patients. These solutions are particularly useful in obstetric, terminally ill, postoperative, and trauma patients. The pumps can be programmed to deliver a specific dosage over a set of periods, ensuring a steady release of pain relief medication.

The increasing prevalence of chronic pain conditions such as failed back syndrome, complex regional pain syndrome (CRPS), myocardial infarction, spinal cord injury, cerebral palsy, and others, among all age groups, especially the geriatric population, is increasing demand for pain management treatments such as analgesic fusion pumps.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Encouraging Adoption of Infusion Pumps?

The prevalence of chronic pain ailments like arthritis, cancer pain, and neuropathic pain across the world among the obese, aged, or other age groups are demanding pain management options, driving demand for analgesic infusion pumps. Likewise, the demand for pain-relieving drug infusers post-surgical procedures is creating room for the Analgesic Infusion Pumps Market.

Also, continuous advancements such as precise dosage control, and remote monitoring, is all possible using smart features such as artificial intelligence, and connected health platforms to help develop a portable and user-friendly solution. Thus, the improvements in pump technology are enhancing the capabilities and user experience of analgesic infusion pumps.

Moreover, the application of effective pain management solutions such as these pumps is increasing owing to initiatives and educational campaigns offering therapeutic benefits and patient satisfaction. Awareness regarding the use of analgesic infusion pumps in home-based care and ambulatory surgical centers is increasing to shorten hospital stays and personalize pain management.

Besides these, high disposable incomes in developing economies is improving accessibility to healthcare services and advanced medical technologies like analgesic infusion pumps, driving their sales.

Despite their high costs and regulatory hurdles, the advantages of the Analgesic Infusion Pumps Market is projected to continue growing in the coming years.

Will High Costs Hinder Growth of the Analgesic Infusion Pumps Market?

The cost of development and maintenance of technologically advanced infusion pumps can be affect the adoption rate by healthcare facilities, particularly those in resource-limited or lower-income settings. This limits their ability to invest in these devices as the needle and syringe used will further add up to the overall cost, potentially hindering patient access to advanced treatment options.

The existence of stringent regulatory requirements for medical devices is likely to extend the approval and expense of the development processes, delaying market entry. This financial expense is likely to burden the manufacturers and healthcare providers.

While pumps offer advantages in some scenarios, convincing healthcare professionals and patients is challenging as alternative pain management options, like oral medications, non-invasive techniques like nerve blocks, and physical therapy are proving effective.

Also, the need for proper training is necessary to avoid human error, which is likely to cause over or underdosing. These risks are majorly impacting the sales of Analgesic Infusion Pumps Market.

The technical limitations such integration with the existing healthcare systems or connective device is complex, expensive, and prone to cyberthreats. Such technological errors along with compatibility issues plummet the adoption rate to a greater extent.

Category- Wise Acumens

Which Product Category Dominates the Analgesic Infusion Pumps Market?

The increasing prevalence of chronic diseases among all age groups, especially aged group, is demanding need for comfortable and self-administer treatment options, thereby bolstering the use of patient-controlled analgesia pumps. This demand is likely to help fuel the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain, chronic pain management, and labor analgesia.

The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients rising preference for these devices owing to its cost-effectiveness compared to other types of pumps is propelling the market. Its role in reducing hospital stays is enables cost-savings as well as remote monitoring. Thus, healthcare manufacturers are their focus on patient-controlled analgesic pumps in compliance with regulatory standards and industrial standards.

Furthermore, the integration of AI, MI, Internet of Things (IoT), and other advanced technologies will modernize these drug delivery systems to an extent offering safety, efficiency, remote monitoring, and accuracy.

Which Factors are Influencing the Growth of Home Care Industry?

As per Verified Market Research, home care segment is projected to experience fastest-growth over the forecast period. There is an increasing demand for patient-centric care and personalized treatment options, creating wider scope of adoption of integration of remote monitoring and telehealth capabilities in analgesic infusion pumps.

Also, a growing preference for familiar and comfortable environments for treatment among the elderly or disease-affected patients is driving the need for home-based medical devices. The high prevalence of chronic illness with acute pain such as cancer, neurological disorder, and arthritis leads to non-pocket-friendly outcomes, thereby encouraging the use of cost-effective chronic pain management or value-based care at home compared to extended hospital stays

The COVID-19 pandemic has accelerated the adoption of home care services as hospitals faced capacity challenges and patients sought to minimize exposure to the virus. The pandemic has reinforced the importance of home-based healthcare, including the use of analgesic infusion pumps.

Country/Region-wise Acumens

What Factors Enable North America Hold Major Share in Analgesic Infusion Pumps Market?

Growing adoption of a sedentary lifestyle, changing dietary habits, and geographical conditions are increasing incidences of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. This creates a substantial market for pain management solutions like analgesic infusion pumps. Primarily, the focus on ensuring whether analgesic infusion pumps meet rigorous safety and efficacy standards before being introduced into the market and fostering trust among healthcare professionals and patients are factors bolstering the demand in North America.

Additionally, the aging population with higher susceptibility to chronic illnesses in North America is leading to a higher demand for healthcare services, including pain management. Thereby, the demand for pain treatment options is creating lucrative opportunities for analgesic infusion pumps in this region.

The region has well-established distribution networks and efficient supply chains for medical devices. This facilitates the easy availability and accessibility of analgesic infusion pumps across healthcare institutions. High levels of healthcare spending is also contributing to the adoption of advanced medical technologies, including analgesic infusion pumps, to improve patient care and outcomes. The advancements in pain management solutions are enabling North America to retain its dominance in the Analgesic Infusion Pumps Market.

How will Surging Demand for Advanced Medical Technologies Affect the Analgesic Infusion Pumps Market in Asia Pacific?

The demand for advanced medical technologies often goes hand-in-hand with an increased awareness and understanding of these technologies among healthcare professionals and patients. This may lead to adoption of analgesic infusion pumps as healthcare providers become more educated about their benefits in managing pain effectively. In response to this technological demand, the market enables Asia Pacific to experience substantial growth over the forecast period.

The rising demand for advanced medical technologies is driving support and investment from government authorities in the research and development in the field of analgesic infusion pumps. This may result in the development of more sophisticated and user-friendly devices with enhanced features, improved safety profiles, and greater precision in drug delivery in the region. Similarly, increasing spending on healthcare by the governments and private healthcare providers in the Asia Pacific is creating opportunities for the growth of the Analgesic Infusion Pumps Market.

The growing demand for analgesic infusion pumps is attracting both local and international manufacturers to the Asia Pacific market. This increased competition may lead to the development of new and improved analgesic infusion pumps with features, such as remote monitoring, bolus dosing, and integration with electronic health records, increasing accessibility, cost-effectiveness, and quality, and ultimately benefiting healthcare providers and patients.

Competitive Landscape

The Analgesic Infusion Pumps Market is intensely competitive, fueled by rapid technological breakthroughs and rising demand for effective pain management solutions. Market competitors are constantly striving to improve the efficiency, safety, and overall performance of infusion pumps to satisfy the changing needs, resulting in a dynamic and competitive environment within the sector.

Some of the prominent players operating in the Analgesic Infusion Pumps Market include:

Medtronic plc, Becton Dickinson and Company (BD), Braun Melsungen AG, Fresenius Kabi AG, Smith's Medical, Terumo Corporation, ICU Medical Inc., Roche Diagnostics (AccuVein), Moog Inc., Animas Corporation, Tandem Diabetes Care Inc., Micrel Medical Devices S.A. (a Mindray Company), Zyno Medical, Sensile Medical AG (a subsidiary of Gerresheimer AG), CME Medical (a BD Company), Zenith Medic (a subsidiary of Smiths Group), Q Core Medical Ltd., Ace Medical Co. Ltd., Nipro Corporation, Chemyx Inc.

Latest Developments

In August 2023, ICU Medical, Inc. (US) received FDA clearance for its Plum Duo infusion Pump, which make it available for customers in the US in early 2024.

In April 2023, Fresenius Kabi (Germany) announced that its Ivenix Infusion System has received on Innovative Technology contract from Vizient, Inc. (US), which sets terms for hospitals to evaluate and purchase the Ivenix Infusion System.

In August 2022, Becton Dickinson and company (Us) Novum IQ Syringe Infusion Pump received FDA Approval.

In March 2022, Fresenius Kabi (Germany) received US FDA approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med Technology.

1. INTRODUCTION OF GLOBAL ANALGESIC INFUSION PUMPS MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL ANALGESIC INFUSION PUMPS MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
4.3. Porters Five Force Model

5. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY PRODUCT

5.1. Overview
5.2 Epidural Pumps
5.3 Intrathecal Pumps
5.4 Patient-Controlled Analgesia Pump (PCA)
5.5 Others

6. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY APPLICATION

6.1. Overview
6.2 Hospitals
6.3 Home Care
6.4 Ambulatory Surgical Centers

7. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY GEOGRAPHY

7.1. Overview
7.2. North America
- 7.2.1. U.S.
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. Europe
- 7.3.1. Germany
- 7.3.2. U.K.
- 7.3.3. France
- 7.3.4. Rest of Europe
7.4. Asia Pacific
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. India
- 7.4.4. Rest of Asia Pacific
7.5. Rest of the World
- 7.5.1. Latin America
- 7.5.2. Middle East & Africa

8. GLOBAL ANALGESIC INFUSION PUMPS MARKET COMPETITIVE LANDSCAPE

8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies

9. COMPANY PROFILES

9.1. Medtronic plc
- 9.1.1. Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Outlook
- 9.1.4. Key Developments
9.2. Becton Dickinson and Company (BD)
- 9.2.1. Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Outlook
- 9.2.4. Key Developments
9.3. Braun Melsungen AG
- 9.3.1. Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Outlook
- 9.3.4. Key Developments
9.4. Fresenius Kabi AG
- 9.4.1. Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Outlook
- 9.4.4. Key Developments
9.5. Smith's Medical
- 9.5.1. Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Outlook
- 9.5.4. Key Developments
9.6. Terumo Corporation
- 9.6.1. Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Outlook
- 9.6.4. Key Developments
9.7. ICU Medical Inc.
- 9.7.1. Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Outlook
- 9.7.4. Key Developments
9.8. Roche Diagnostics (AccuVein)
- 9.8.1. Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Outlook
- 9.8.4. Key Developments
9.9. Moog Inc.
- 9.9.1. Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Outlook
- 9.9.4. Key Developments
9.10. Animas Corporation
- 9.10.1. Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Outlook
- 9.10.4. Key Developments